The final, formatted version of the article will be published soon.
EDITORIAL article
Front. Pharmacol.
Sec. Neuropharmacology
Volume 15 - 2024 |
doi: 10.3389/fphar.2024.1426157
This article is part of the Research Topic Exploring Neuroinflammatory Pathways that Contribute to Chronic Pain, Volume II View all 5 articles
Editorial on the Research Topic Exploring Neuroinflammatory Pathways that Contribute to Chronic Pain, Volume II
Provisionally accepted- 1 University of Hertfordshire, Hatfield, United Kingdom
- 2 GW Pharmaceuticals, Cambridge, United Kingdom
Keywords: Neuroinflammation, neuropathic pain, STAT2, PPAR γ, CX3CR1, Progesterone, ncRNA
Received: 30 Apr 2024; Accepted: 07 May 2024.
Copyright: © 2024 Lione and Fisher. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Lisa A. Lione, University of Hertfordshire, Hatfield, United Kingdom
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.